Attached files
| file | filename |
|---|---|
| EX-14 - NOVAVAX INC | v176992_ex14.htm |
| EX-10.14 - NOVAVAX INC | v176992_ex10-14.htm |
| EX-10.45 - NOVAVAX INC | v176992_ex10-45.htm |
| EX-10.15 - NOVAVAX INC | v176992_ex10-15.htm |
| EX-10.11 - NOVAVAX INC | v176992_ex10-11.htm |
| EX-10.19 - NOVAVAX INC | v176992_ex10-19.htm |
| EX-10.13 - NOVAVAX INC | v176992_ex10-13.htm |
| EX-10.37 - NOVAVAX INC | v176992_ex10-37.htm |
| EX-23.1 - NOVAVAX INC | v176992_ex23-1.htm |
| EX-31.2 - NOVAVAX INC | v176992_ex31-2.htm |
| EX-31.1 - NOVAVAX INC | v176992_ex31-1.htm |
| EX-32.2 - NOVAVAX INC | v176992_ex32-2.htm |
| 10-K - NOVAVAX INC | v176992_10k.htm |
Exhibit
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER PURSUANT
TO
18 UNITED STATES C. §1350
(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002)
In
connection with the Annual Report of Novavax, Inc. (the “Company”) on Form 10-K
for the fiscal year ended December 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Rahul Singhvi,
President and Chief Executive Officer of the Company, hereby certify, pursuant
to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company for the dates
and periods covered by this Report.
|
By:
|
/s/ Rahul Singhvi
|
|
Title:
|
President
and Chief Executive Officer
|
Date:
March 16, 2010